Savant Capital, LLC Abbott Laboratories Transaction History

Savant Capital, LLC

  • $11.7 Billion
  • Q3 2024

A detailed history of Savant Capital, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Savant Capital, LLC holds 118,264 shares of ABT stock, worth $13.5 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
118,264
Previous 108,293 9.21%
Holding current value
$13.5 Million
Previous $11.3 Million 19.83%
% of portfolio
0.11%
Previous 0.11%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024
BUY
$100.07 - $118.13 $997,797 - $1.18 Million
9,971 Added 9.21%
118,264 $13.5 Million
Q2 2024

Aug 05, 2024
SELL
$100.73 - $112.44 $328,279 - $366,441
-3,259 Reduced 2.92%
108,293 $11.3 Million
Q1 2024

May 03, 2024
BUY
$109.52 - $120.96 $70,311 - $77,656
642 Added 0.58%
111,552 $12.7 Million
Q4 2023

Feb 05, 2024
BUY
$90.19 - $110.4 $359,767 - $440,385
3,989 Added 3.73%
110,910 $12.2 Million
Q3 2023

Nov 06, 2023
BUY
$95.53 - $114.62 $247,900 - $297,438
2,595 Added 2.49%
106,921 $10.4 Million
Q2 2023

Aug 04, 2023
BUY
$100.78 - $112.29 $1.53 Million - $1.71 Million
15,213 Added 17.07%
104,326 $11.4 Million
Q1 2023

May 02, 2023
BUY
$96.86 - $114.01 $685,381 - $806,734
7,076 Added 8.63%
89,113 $9.02 Million
Q4 2022

Feb 06, 2023
BUY
$95.06 - $111.52 $150,004 - $175,978
1,578 Added 1.96%
82,037 $9.01 Million
Q3 2022

Oct 28, 2022
SELL
$96.76 - $112.03 $779,111 - $902,065
-8,052 Reduced 9.1%
80,459 $7.79 Million
Q2 2022

Jul 22, 2022
BUY
$102.07 - $123.37 $393,479 - $475,591
3,855 Added 4.55%
88,511 $9.62 Million
Q1 2022

May 05, 2022
BUY
$114.02 - $139.04 $289,496 - $353,022
2,539 Added 3.09%
84,656 $10 Million
Q4 2021

Feb 08, 2022
BUY
$115.53 - $141.46 $232,446 - $284,617
2,012 Added 2.51%
82,117 $11.6 Million
Q3 2021

Nov 12, 2021
BUY
$116.66 - $129.06 $127,626 - $141,191
1,094 Added 1.38%
80,105 $9.46 Million
Q2 2021

Aug 04, 2021
BUY
$105.79 - $124.53 $174,024 - $204,851
1,645 Added 2.13%
79,011 $9.16 Million
Q1 2021

May 04, 2021
BUY
$108.84 - $128.23 $495,766 - $584,087
4,555 Added 6.26%
77,366 $9.27 Million
Q4 2020

Feb 03, 2021
SELL
$105.0 - $114.42 $23,835 - $25,973
-227 Reduced 0.31%
72,811 $7.97 Million
Q3 2020

Nov 04, 2020
BUY
$91.64 - $111.29 $5,681 - $6,899
62 Added 0.08%
73,038 $7.95 Million
Q2 2020

Aug 11, 2020
SELL
$76.57 - $98.0 $29,020 - $37,142
-379 Reduced 0.52%
72,976 $6.67 Million
Q1 2020

Apr 30, 2020
BUY
$62.82 - $91.86 $765,964 - $1.12 Million
12,193 Added 19.94%
73,355 $5.79 Million
Q4 2019

Jan 31, 2020
BUY
$78.51 - $87.4 $68,225 - $75,950
869 Added 1.44%
61,162 $5.31 Million
Q3 2019

Nov 12, 2019
BUY
$81.84 - $88.74 $23,651 - $25,645
289 Added 0.48%
60,293 $5.05 Million
Q2 2019

Aug 06, 2019
BUY
$72.88 - $85.0 $3,279 - $3,825
45 Added 0.08%
60,004 $5.05 Million
Q1 2019

May 02, 2019
BUY
$66.22 - $80.06 $31,123 - $37,628
470 Added 0.79%
59,959 $4.79 Million
Q4 2018

Feb 05, 2019
SELL
$65.56 - $74.27 $21,634 - $24,509
-330 Reduced 0.55%
59,489 $4.3 Million
Q3 2018

Oct 23, 2018
SELL
$60.81 - $73.36 $14,351 - $17,312
-236 Reduced 0.39%
59,819 $4.39 Million
Q2 2018

Aug 07, 2018
BUY
$57.57 - $63.54 $64,190 - $70,847
1,115 Added 1.89%
60,055 $3.66 Million
Q1 2018

Apr 27, 2018
BUY
$56.27 - $63.62 $146,020 - $165,093
2,595 Added 4.61%
58,940 $3.53 Million
Q4 2017

Jan 31, 2018
BUY
$53.68 - $57.47 $13,527 - $14,482
252 Added 0.45%
56,345 $3.22 Million
Q3 2017

Oct 31, 2017
BUY
$48.06 - $53.64 $2.7 Million - $3.01 Million
56,093
56,093 $2.99 Million

Others Institutions Holding ABT

# of Institutions
3,187
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $199B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Savant Capital, LLC Portfolio

Follow Savant Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Savant Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Savant Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email